These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4722209)

  • 1. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G; Keller HH; Pletscher A
    Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological and molecular biochemistry.
    Andén NE; Bartholini G; Corrodi H; Csillik B; De Robertis E; Dresse A; Fuxe K; Gerebtzoff MA; Glowinski J; Hansson E; Hökfelt T; Renson J; Roos BE
    Mod Probl Pharmacopsychiatry; 1970; 5():1-11. PubMed ID: 4348145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of neuroleptics on the content of dopamine and DOPAC in the caudate nucleus of the rat].
    Gérardy J; Dresse A
    Experientia; 1974 May; 30(5):523-4. PubMed ID: 4833680
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 9. Copulatory behavior in the male rat after impaired monoaminergic neurotransmission.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():69-95. PubMed ID: 4136131
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.
    Andén NE; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1971 Jul; 15(2):193-9. PubMed ID: 4341651
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
    Fujimori K; Iwamoto T
    Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues.
    Green AL
    J Pharm Pharmacol; 1973 Mar; 25(3):267-9. PubMed ID: 4146333
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
    Pycock C; Tarsy D; Marsden CD
    Psychopharmacologia; 1975 Dec; 45(2):211-9. PubMed ID: 1240638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 17. The dopamine-releasing actions of neuroleptics and ethanol.
    Seeman P; Lee T
    J Pharmacol Exp Ther; 1974 Jul; 190(1):131-40. PubMed ID: 4847309
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of some psychoactive agents on prolactin secretion in rats of different endocrine states.
    Clemens JA; Shaar CJ; Smalstig EB; Matsumoto C
    Horm Metab Res; 1974 May; 6(3):187-90. PubMed ID: 4834662
    [No Abstract]   [Full Text] [Related]  

  • 19. Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
    Choudhury SA; Sharpe RM; Brown PS
    Neuroendocrinology; 1973; 12(4):272-83. PubMed ID: 4731030
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of brain noradrenaline in morphine-induced stereotyped behaviour.
    Ayhan IH; Randrup A
    Psychopharmacologia; 1972; 27(3):203-12. PubMed ID: 4674514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.